Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)
Public ClinicalTrials.gov record NCT04065490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Masked, Randomized, Sham-Controlled, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Photobiomodulation (PBM) in Subjects With Dry Age-Related Macular Degeneration (AMD) (LIGHTSITE III)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with dry AMD. Alcon Research, LLC, acquired LumiThera in September 2025.
Study identification
- NCT ID
- NCT04065490
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2019 (Actual)
- Primary completion
- Jan 24, 2023 (Actual)
- Completion
- Nov 1, 2024 (Actual)
- Last update posted
- Oct 8, 2026
2019 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| Stanford University | Palo Alto | California | 94303 | — |
| Florida Eye Clinic | Altamonte Springs | Florida | 32701 | — |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21749 | — |
| Mid Atlantic Retina | Cherry Hill | New Jersey | 19107 | — |
| New York Ear and Eye Infirmary | New York | New York | 10003-4284 | — |
| Duke Eye Center | Durham | North Carolina | 27705 | — |
| Cumberland Valley Retina Consultants | Chambersburg | Pennsylvania | 17201 | — |
| Gulf Coast Eye Institute | McAllen | Texas | 78503 | — |
| Retina Center Northwest | Silverdale | Washington | 98383 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04065490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04065490 live on ClinicalTrials.gov.